Scarica l'app Stockscreener
3.35
0.60%
0.02
Pre-mercato:
3.06
-0.29
-8.66%
Precedente Chiudi:
$3.33
Aprire:
$3.25
Volume 24 ore:
1.40M
Relative Volume:
1.34
Capitalizzazione di mercato:
$228.92M
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-1.5581
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
-20.24%
1M Prestazione:
-20.43%
6M Prestazione:
-71.02%
1 anno Prestazione:
-69.77%
Intervallo 1D:
$3.15
$3.43
Intervallo di 1 settimana:
$3.15
$4.255
Portata 52W:
$3.15
$16.62
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
3.35 | 228.92M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 66.76B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-02 | Iniziato | Goldman | Buy |
| 2024-01-30 | Iniziato | Citigroup | Buy |
| 2023-07-21 | Iniziato | Oppenheimer | Outperform |
| 2023-05-05 | Iniziato | CapitalOne | Overweight |
| 2023-02-22 | Iniziato | Credit Suisse | Outperform |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
| 2021-12-07 | Ripresa | Cowen | Outperform |
| 2020-12-14 | Iniziato | Canaccord Genuity | Buy |
| 2020-12-14 | Iniziato | Cowen | Outperform |
| 2020-12-14 | Iniziato | JP Morgan | Overweight |
| 2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
HighTower Advisors LLC Makes New $510,000 Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
10,352 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Bought by Teacher Retirement System of Texas - Defense World
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Olema Expands Team: 5 Key Hires Receive Equity Compensation Package - Stock Titan
Top Premarket Decliners - MarketScreener
Insiders Could Have Profited By Holding onto Olema Pharmaceuticals Shares Despite 13% Drop - simplywall.st
Olema Pharmaceuticals stock hits 52-week low at $3.86 By Investing.com - Investing.com South Africa
Olema Pharmaceuticals stock hits 52-week low at $3.86 - Investing.com
HighTower Advisors LLC Takes $510,000 Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
JPMorgan Chase & Co. Lowers Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 - MarketBeat
Pier Capital LLC Acquires New Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Bank of New York Mellon Corp Trims Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology to Present Preclinical Data for OP-3136, a - GlobeNewswire
Victory Capital Management Inc. Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Cancer Breakthrough: New Drug Shows Powerful Anti-Tumor Effects in Prostate, Ovarian, Lung Cancers - Stock Titan
What is Lifesci Capital's Estimate for OLMA FY2025 Earnings? - MarketBeat
HC Wainwright Has Positive Forecast for OLMA Q1 Earnings - MarketBeat
What is HC Wainwright's Forecast for OLMA FY2029 Earnings? - MarketBeat
Olema Pharmaceuticals' (OLMA) "Outperform" Rating Reiterated at Oppenheimer - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Victory Capital Management Inc. Sells 758,412 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
HC Wainwright Issues Optimistic Outlook for OLMA Earnings - Defense World
FY2025 EPS Estimate for Olema Pharmaceuticals Cut by Analyst - Defense World
Olema Pharmaceuticals Inc (OLMA) Shares Rise Despite Market Challenges - The News Heater
Olema Oncology Reports 2024 Financial and Clinical Progress - TipRanks
Olema Pharmaceuticals (NASDAQ:OLMA) Earns “Outperform” Rating from Oppenheimer - Defense World
What is HC Wainwright’s Forecast for OLMA FY2029 Earnings? - Defense World
HC Wainwright Reiterates “Buy” Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals stock hits 52-week low at $3.94 By Investing.com - Investing.com Australia
Olema Pharmaceuticals stock hits 52-week low at $3.94 - Investing.com India
Olema Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire
Olema Oncology price target lowered to $25 from $30 at Oppenheimer - TipRanks
Olema Pharmaceuticals Q4 Net Loss Widens -March 18, 2025 at 04:37 pm EDT - Marketscreener.com
Olema Pharmaceuticals Inc Reports Q4 2024 EPS of -$0.63 and Net - GuruFocus.com
Olema Pharmaceuticals, Inc. SEC 10-K Report - TradingView
Olema Pharmaceuticals Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):